Targeted Action and Financing the Fight Against Antimicrobial Resistance in Asia 2025

Similarly, catalytic funders have an important role to play in helping to build better health systems and infrastructure, enhance education and awareness, and cultivate skilled talent for the long term (see Figure 12). In the fight against the superbugs that threaten to cast a shadow over every hospital bed, every surgical theatre and every scraped knee, there is a pressing need for everyone to step up and preserve the efficacy of the life-saving drugs that exist, as well as invest in the talent and capabilities needed to find new treatments.CASE STUDY 11 Industry commitment to Indonesia’s National Action Plan for Antimicrobial Resistance Control During World Antimicrobial Awareness Week 2022, representatives from Indonesia’s Ministry of Agriculture, WOAH, FAO and the poultry and pharmaceutical industries in Indonesia signed a joint declaration committing to the responsible use of antimicrobials. The poultry and pharmaceutical sectors were represented by six corporations – Charoen Pokphand Indonesia, Japfa Comfeed Indonesia, Medion Farma Jaya, Satya Samitra Niagatama, Agrinusa Jaya Santosa and Elanco Animal Health Indonesia. The declaration outlined five key points to guide the implementation of policies for the industry: 1. Wise use of antimicrobials of the right type and dosage for the recommended period according to prescription. 2. Improvements to biosecurity and vaccination to reduce infection rates.3. Reduced use of antimicrobials on farms and implementation of good waste management. 4. Investments into vaccines, innovative antimicrobials and new technologies. 5. Collaboration with academia to share data and information to combat AMR. The joint declaration followed from commitments made during the G20 meeting in Bali and aligned with Indonesia’s National Action Plan for Antimicrobial Resistance Control. Given the growth expected in the country’s livestock production sector and a shift towards integrated production companies, these six corporations are well positioned to encourage other industrial actors to join the fight against AMR. Sources: See endnote.164 Targeted Action and Financing the Fight Against Antimicrobial Resistance in Asia 38